简体中文
简体中文
According to the requirements of relevant laws and regulations, the environmental protection acceptance report for the completion of Shandong Loncom Pharmaceutical Co., Ltd.-an annual output of 15,000 kg of rosuvastatin calcium and new drug research and develo...
Time：2020.11.30
2020年10月16日至10月20日，受国家药品监督管理局食品药品审核查验中心及山东省药品监督管理局查验中心委派，检查组一行六人对百诺医药研制现场和朗诺制药生产现场进行了为期5天的地氯雷他定原料药的药品注册现场核查和GMP符合性检查。
Time：2020.11.02
Shandong Loncom Pharmaceutical Co., Ltd is located in the east of Jingqi Road, Qihe Economic Development Zone. At present, the company's main production and operation products are rosuvastatin calcium API .
Time：2020.05.29
Shandong Loncom Pharmaceutical Co., Ltd's annual output of 15,000 kg of rosuvastatin calcium production and new drug research and development base project is located in Qihe Economic Development Zone.
Time：2020.05.29
According to the "People's Republic of China Environmental Impact Assessment Law", "Environmental Impact Assessment Public Participation Measures" and the relevant provisions of the environmental impact assessment of construction projects
Time：2020.05.28
086-0531-88072380
